MOONLAKE IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 61559X104. A total of 133 filers reported holding MOONLAKE IMMUNOTHERAPEUTICS in Q4 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $784,000 | -84.0% | 17,836 | -81.7% | 0.00% | -100.0% |
| Q1 2024 | $4,895,000 | +202.5% | 97,474 | +263.9% | 0.00% | – |
| Q4 2023 | $1,618,000 | +17.8% | 26,788 | +11.2% | 0.00% | – |
| Q3 2023 | $1,373,000 | +33.3% | 24,083 | +19.2% | 0.00% | – |
| Q2 2023 | $1,030,000 | +7257.1% | 20,196 | +2978.7% | 0.00% | – |
| Q1 2023 | $14,000 | +1300.0% | 656 | +763.2% | 0.00% | – |
| Q4 2022 | $1,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 21,751,284 | $465,259,965 | 17.01% |
| Cormorant Asset Management, LP | 6,892,101 | $147,422 | 9.71% |
| HighVista Strategies LLC | 122,201 | $2,613,879 | 2.13% |
| Ally Bridge Group (NY) LLC | 72,850 | $1,558,262 | 2.04% |
| Ghost Tree Capital, LLC | 195,000 | $4,171,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 278,334 | $5,953,564 | 1.17% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,750 | $2,261,993 | 0.93% |
| SVB FINANCIAL GROUP | 16,173 | $345,940 | 0.66% |
| Velan Capital Investment Management LP | 23,400 | $500,526 | 0.43% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 14,500 | $310,155 | 0.25% |